Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. The company was founded in 2004 and is based in New York, New York. Show more
149 Fifth Avenue, New York, NY, 10010, United States
Market Cap
2.172M
52 Wk Range
$0.13 - $4.55
Previous Close
$0.98
Open
$1.11
Volume
30,102
Day Range
$1.11 - $1.23
Enterprise Value
3.476M
Cash
2.213M
Avg Qtr Burn
-509.7K
Insider Ownership
6.20%
Institutional Own.
4.64%
Qtr Updated
12/31/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
PT00114 Details Major depression, anxiety disorders, PTSD, addiction / substance use disorders | Phase 2 Initiation |